Detalhe da pesquisa
1.
Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer: a multicentre external validation in patients who underwent surgery.
Br J Cancer
; 130(6): 934-940, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38243011
2.
Do autoimmune diseases influence the onset and progression of ovarian cancer? A systematic review and meta-analysis.
Int J Gynecol Cancer
; 32(12): 1583-1591, 2022 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36028235
3.
TIM3 Checkpoint Inhibition Fails to Prolong Survival in Ovarian Cancer-Bearing Mice.
Cancers (Basel)
; 16(6)2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38539483
4.
Toward more accurate preclinical glioblastoma modeling: Reverse translation of clinical standard of care in a glioblastoma mouse model.
Methods Cell Biol
; 183: 381-397, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38548420
5.
Preclinical studies performed in appropriate models could help identify optimal timing of combined chemotherapy and immunotherapy.
Front Immunol
; 14: 1236965, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37744323
6.
Drug Repurposing for Targeting Myeloid-Derived Suppressor-Cell-Generated Immunosuppression in Ovarian Cancer: A Literature Review of Potential Candidates.
Pharmaceutics
; 15(7)2023 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37513979
7.
A Microfluidics Approach for Ovarian Cancer Immune Monitoring in an Outpatient Setting.
Cells
; 13(1)2023 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38201211
8.
Effect of Particle Carriers for Intraperitoneal Drug Delivery on the Course of Ovarian Cancer and Its Immune Microenvironment in a Mouse Model.
Pharmaceutics
; 14(4)2022 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35456521
9.
Type of chemotherapy has substantial effects on the immune system in ovarian cancer.
Transl Oncol
; 14(6): 101076, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33770618
10.
Neo-Adjuvant Chemotherapy Reduces, and Surgery Increases Immunosuppression in First-Line Treatment for Ovarian Cancer.
Cancers (Basel)
; 13(23)2021 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34885008
11.
Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer.
J Immunother Cancer
; 9(11)2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34795003
12.
Opposite Macrophage Polarization in Different Subsets of Ovarian Cancer: Observation from a Pilot Study.
Cells
; 9(2)2020 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32012728
13.
Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer.
Front Immunol
; 10: 1273, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31214202